Lilly's Prices After Concessions Rise 6% In 2017, While Merck's Net Prices Decline

Price transparency reports from the big pharmas also show continued increases in price concessions in 2017, but a slow-down in list price increases.

group of businessman in black suit and holding red arrow down graph

More from Pricing Debate

More from Market Access